930 WINTER STREET, WALTHAM, MA
Jade Biosciences Approves 2026 Employment Inducement Stock Plan
Financial Results, Press Release
Jade Biosciences Targets 2026 Goals for Monoclonal Antibodies in Autoimmune Diseases
Announces $45 Million Private Placement
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Investor Presentation
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
S-1
Definitive Proxy Statement
Additional Proxy Materials
Post-Effective Amendment
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership